[EFFECT OF NEW ANDROGEN RECEPTOR AXIS-TARGETED AGENTS ON SURVIVAL OF CASTRATION-RESISTANT PROSTATE CANCER].

Shimabukuro, Tomoyuki; Ohmi, Chietaka; Nagamitsu, Ryoko; Shiraishi, Koji

Shimabukuro, Tomoyuki; Ohmi, Chietaka; Nagamitsu, Ryoko; Shiraishi, Koji.

Afiliação

Shimabukuro T; Department of Urology, Ube-kosan Central Hospital Corp.
Ohmi C; Department of Urology, Graduate School of Medicine, Yamaguchi University.
Nagamitsu R; Department of Urology, Ube-kosan Central Hospital Corp.
Shiraishi K; Department of Urology, Ube-kosan Central Hospital Corp.

Nihon Hinyokika Gakkai Zasshi ; 112(4): 207-214, 2021.

Article em Ja | MEDLINE | ID: mdl-36261351

Palavras-chave

castration-resistant prostate cancer; new androgen receptor axis-targeted agents; survival

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: Ja Revista: Nihon Hinyokika Gakkai Zasshi Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google